RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

57 hedge funds and large institutions have $129M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$5.6M
2 +$4.89M
3 +$3.34M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$3.23M
5
EA
Emerald Advisers
Pennsylvania
+$1.15M

Top Sellers

1 -$87.8M
2 -$1.13M
3 -$829K
4
Millennium Management
Millennium Management
New York
-$727K
5
Bessemer Group
Bessemer Group
New Jersey
-$483K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$18.8M
2
$14.5M
3
$13.1M
4
$12.9M
5
$9.35M
6
$9.3M
7
$7.91M
8
$7.36M
9
$3.42M
10
$3.1M
11
$2.85M
12
$2.5M
13
$2.3M
14
$2.21M
15
$2.16M
16
$1.77M
17
$1.11M
18
$1.1M
19
$1.07M
20
$861K
21
$729K
22
$689K
23
$665K
24
$664K
25
$625K